ReviewBiomaterials2026
Wearable bioelectronics for skin cancer management.
Review in Biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bioelectronic Considerations in Biomedical Microneedles.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Post-oncologic skin health: cutaneous recovery and rehabilitation after cancer treatments.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Wearable bioelectronics have transformed modern biomedical applications by enabling seamless integration with biological tissues, providing continuous, comprehensive, and personalized healthcare. Skin cancer, particularly melanoma, poses a significant clinical challenge due to its high metastatic potential and associated mortality. Traditional diagnostic approaches face limitations in accuracy, accessibility, and reproducibility, while existing treatments are often constrained by systemic toxicity and therapeutic resistance. Wearable bioelectronics offer innovative solutions for both diagnosis and treatment. Advanced platforms incorporating cutting-edge technologies optimize diagnostic accuracy and treatment precision. This review systematically examines the recent advancements in wearable bioelectronics for skin cancer management. Firstly, the pathological mechanisms underlying skin cancer is discussed. Next, we discuss the wearable optical and electrochemical sensing technologies for early and non-invasive cancer screening. We further evaluate wearable therapeutic platforms, for chemotherapy, photodynamic therapy, electrotherapy, and immunotherapy, along with combinatorial cancer treatment strategies. Key device attributes-including integration, mechanical properties, and biocompatibility-are analyzed to highlight their role in optimizing cancer treatment performance and patient compliance. Finally, we address major challenges, including technological bottlenecks and barriers to clinical translation, while proposing future research directions to enhance the applicability of wearable bioelectronics in precision oncology. By integrating interdisciplinary innovations, wearable devices have the potential to redefine skin cancer diagnosis and treatment, offering safer, more effective, and patient-centered solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.